| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |